These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3012833)

  • 1. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
    Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
    Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
    Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
    Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
    Boström L; Ringdén O; Forsgren M
    Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
    Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
    Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients.
    Li Volti S; Mauro L; Di Gregorio F; Romeo MA; Lupo L; Pizzarelli G; Mangiagli A; Giammanco G; Russo G
    Bone Marrow Transplant; 1994 Aug; 14(2):225-7. PubMed ID: 7994236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus immunity in allogeneic marrow grafting.
    Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
    Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
    Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
    Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of pretransplant viral serology and complications of bone marrow transplantation.
    Ringdén O
    Ann Hematol; 1992 Jun; 64 Suppl():A143-7. PubMed ID: 1322186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS; Miller W; Haake R; Weisdorf D
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
    Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
    Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infections in leukemia and bone marrow transplant patients.
    Wingard JR
    Leuk Lymphoma; 1993; 11 Suppl 2():115-25. PubMed ID: 8124223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation.
    Barberà JA; Martín-Campos JM; Ribalta T; Carreras E; Liopart A; Sierra J; Rozman C; Rodríguez-Roisin R
    Eur Respir J; 1996 Jun; 9(6):1195-200. PubMed ID: 8804937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral serology after bone marrow transplantation.
    Epstein JB; Phillips K; Sherlock CH
    Viral Immunol; 1991; 4(2):133-7. PubMed ID: 1662045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.